The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Treatment for Hepatitis C Genotype 2

Back to News Homepage

Next

Gilead’s Hep C Regimens Progressing Forward

Discovery of Genetic Protein that Impacts Hepatitis C Recovery

January 9, 2013

Print this page

Genetic scientists at the National Institutes of Health have recently found a variant on chromosome 19 that interferes with successful Hepatitis C treatment – a discovery that could lead to better understanding and management of this virus.

Hepatitis-C Virus Treatment Affected By Newly Discovered Gene Mutation: NIH

Added by GM on January 7, 2013.

The National Institutes of Health, (NIH), a division of the U.S. Department of Health and Human Services (HHS), announced in a press release dated 1/6/2013 that scientists from the National Cancer Institute (NCI) have discovered a gene mutation that affects the treatment of the Hepatitis C virus.

Scientists have discovered a gene that interferes with the clearance of hepatitis C virus infection. They also identified an inherited variant within this gene, Interferon Lambda 4 (IFNL4), that predicts how people respond to treatment for hepatitis C infection. The results of this study, by investigators at the National Cancer Institute (NCI), part of the NIH, and their collaborators at NIH and other institutions, were published online in Nature Genetics on Jan. 6, 2013.

Continue reading this entire article:
http://guardianlv.com/2013/01/hepatitis-c-virus-treatment-affected-by-newly-discovered-gene-mutation-nih/

3 Comments
Share
Share

Previous

Treatment for Hepatitis C Genotype 2

Back to News Homepage

Next

Gilead’s Hep C Regimens Progressing Forward

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.